Facebook Linkedin RSS Twitter Youtube
Home 2017

Ono Pharmaceuticals

Numab, Ono Ink CHF258M Deal for Multispecific Immuno-Oncology Antibody
Drug Discovery

Numab, Ono Ink CHF258M Deal for Multispecific Immuno-Oncology Antibody

X-Chem, Ono Pursue Cancer Targets in Drug Discovery Collaboration
Cancer

X-Chem, Ono Pursue Cancer Targets in Drug Discovery Collaboration

Gilead Sciences and Ono Partner to Tackle B-Cell Malignancies
Cancer

Gilead Sciences and Ono Partner to Tackle B-Cell Malignancies

Scil, Ono Establish Affilin Therapeutics Discovery, Development Collaboration
Drug Discovery

Scil, Ono Establish Affilin Therapeutics Discovery, Development Collaboration

Ono, Receptos Ink GPCR Drug Discovery Collaboration
Drug Discovery

Ono, Receptos Ink GPCR Drug Discovery Collaboration

Merck Serono and Ono Sign Separate Agreements Worth $25M for MS and Cancer Drugs
Cancer

Merck Serono and Ono Sign Separate Agreements Worth $25M for MS and Cancer Drugs

BMS and Ono Expand Cancer Antibody Deal and Agree to Partner Orencia in Japan
Cancer

BMS and Ono Expand Cancer Antibody Deal and Agree to Partner Orencia in Japan

Ansaris Reports Lead Compound Identification under Collaboration with Ono Pharmaceutical
Cancer

Ansaris Reports Lead Compound Identification under Collaboration with Ono Pharmaceutical

Ono Nabs Japanese Rights to Onyx’ Registrational-Stage Carfilzomib for $59M
Cancer

Ono Nabs Japanese Rights to Onyx’ Registrational-Stage Carfilzomib for $59M

Ono Taps Evotec for Discovery Work
News

Ono Taps Evotec for Discovery Work

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.